Cargando…
LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer
The efficacy of gemcitabine therapy is often insufficient for the treatment of pancreatic cancer. The current study demonstrated that LW6, a chemical inhibitor of hypoxia-inducible factor 1α, is a promising drug for enhancing the chemosensitivity to gemcitabine. LW6 monotherapy and the combination t...
Autores principales: | Zhang, Xianbin, Kumstel, Simone, Jiang, Ke, Meng, Songshu, Gong, Peng, Vollmar, Brigitte, Zechner, Dietmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514270/ https://www.ncbi.nlm.nih.gov/pubmed/31193017 http://dx.doi.org/10.1016/j.jare.2019.04.006 |
Ejemplares similares
-
Metformin and LW6 impairs pancreatic cancer cells and reduces nuclear localization of YAP1
por: Zhang, Xianbin, et al.
Publicado: (2020) -
Grading Distress of Different Animal Models for Gastrointestinal Diseases Based on Plasma Corticosterone Kinetics
por: Kumstel, Simone, et al.
Publicado: (2019) -
Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin
por: Zechner, Dietmar, et al.
Publicado: (2016) -
Benefits of non-invasive methods compared to telemetry for distress analysis in a murine model of pancreatic cancer
por: Kumstel, Simone, et al.
Publicado: (2019) -
Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines
por: Zechner, Dietmar, et al.
Publicado: (2017)